Stocks Overview

LAST PRICE
2.4300
TODAY'S CHANGE (%)
Trending Down-0.0600 (-2.4096%)

Bid / Lots
2.4300/ 20
Ask / Lots
2.4500/ 8
Open / Previous Close
2.5700 / 2.4900
Day Range
Low 2.4300
High 2.6678
52 Week Range
Low 2.1900
High 3.4547
Volume
372,348
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 2.49
Time	Volume	NAUT
09:32 ET	9816	2.58
09:33 ET	20036	2.65
09:35 ET	100	2.65
09:37 ET	8907	2.66
09:39 ET	500	2.65
09:42 ET	2800	2.65
09:44 ET	972	2.65
09:46 ET	2500	2.65
09:48 ET	3800	2.65
09:50 ET	1400	2.65
09:51 ET	1478	2.65
09:53 ET	67654	2.55
09:55 ET	1400	2.54
09:57 ET	1900	2.51
10:00 ET	3000	2.5
10:02 ET	1250	2.465
10:04 ET	1026	2.485
10:06 ET	1198	2.44
10:08 ET	3394	2.47
10:09 ET	700	2.47
10:11 ET	2204	2.47
10:13 ET	1110	2.44
10:15 ET	2700	2.445
10:18 ET	4373	2.44
10:20 ET	7400	2.4603
10:24 ET	1100	2.475
10:29 ET	488	2.46
10:31 ET	1478	2.45
10:33 ET	2917	2.45
10:36 ET	7227	2.445
10:38 ET	9120	2.45
10:42 ET	100	2.46
10:45 ET	100	2.46
10:47 ET	1123	2.46
10:49 ET	600	2.45
10:51 ET	1306	2.44
10:54 ET	1600	2.43
10:56 ET	2800	2.445
10:58 ET	500	2.47
11:00 ET	500	2.48
11:02 ET	2053	2.48
11:03 ET	1544	2.49
11:05 ET	367	2.48
11:07 ET	1502	2.49
11:09 ET	900	2.49
11:12 ET	600	2.48
11:14 ET	790	2.47
11:16 ET	400	2.47
11:18 ET	790	2.48
11:20 ET	600	2.47
11:21 ET	700	2.47
11:23 ET	800	2.47
11:25 ET	980	2.48
11:27 ET	1700	2.49
11:30 ET	387	2.5
11:32 ET	500	2.48
11:34 ET	778	2.49
11:36 ET	800	2.52
11:38 ET	673	2.51
11:39 ET	900	2.52
11:41 ET	851	2.5221
11:43 ET	600	2.52
11:45 ET	500	2.52
11:48 ET	900	2.52
11:50 ET	1700	2.52
11:52 ET	500	2.52
11:54 ET	800	2.52
11:56 ET	800	2.52
11:57 ET	700	2.525
11:59 ET	600	2.52
12:01 ET	1895	2.52
12:03 ET	700	2.52
12:06 ET	800	2.52
12:08 ET	500	2.52
12:10 ET	900	2.52
12:12 ET	500	2.52
12:14 ET	700	2.52
12:15 ET	700	2.52
12:17 ET	600	2.52
12:19 ET	700	2.525
12:21 ET	500	2.52
12:24 ET	800	2.52
12:26 ET	9633	2.52
12:28 ET	300	2.52
12:30 ET	690	2.52
12:32 ET	937	2.5201
12:33 ET	800	2.52
12:35 ET	400	2.52
12:37 ET	700	2.52
12:39 ET	1400	2.52
12:42 ET	700	2.52
12:44 ET	400	2.52
12:46 ET	500	2.52
12:48 ET	600	2.52
12:50 ET	400	2.52
12:51 ET	16544	2.52
12:53 ET	800	2.52
12:55 ET	800	2.52
12:57 ET	2106	2.54
01:00 ET	120	2.5499
01:02 ET	1000	2.53
01:04 ET	700	2.52
01:06 ET	400	2.52
01:08 ET	600	2.52
01:09 ET	58022	2.49
01:11 ET	500	2.47
01:13 ET	1075	2.46
01:15 ET	857	2.445
01:18 ET	4100	2.45
01:22 ET	3595	2.47
01:24 ET	395	2.45
01:26 ET	492	2.455
01:27 ET	1089	2.44
01:29 ET	2146	2.48
01:31 ET	200	2.47
01:33 ET	1000	2.46
01:36 ET	1300	2.47
01:38 ET	500	2.47
01:40 ET	1596	2.49
01:44 ET	1800	2.48
01:45 ET	1200	2.47
01:47 ET	369	2.46
01:49 ET	1100	2.46
01:51 ET	1100	2.465
01:54 ET	1500	2.48
01:56 ET	500	2.47
01:58 ET	1895	2.46
02:00 ET	365	2.45
02:02 ET	391	2.45
02:03 ET	667	2.44
02:05 ET	1733	2.45
02:07 ET	500	2.44
02:09 ET	800	2.43
02:12 ET	1900	2.43
02:14 ET	400	2.43
02:16 ET	2500	2.43

Data delayed at least 15 minutes.

Oct 31, 2024
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
- Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 29, 2024
- Nautilus Biotechnology Reports Third Quarter 2024 Financial Results, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
- Press Release: Nautilus Biotechnology Reports Third Quarter 2024 Financial Results, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesNAUT Nautilus Biotechnology Inc	312.7M	-4.3x	---
United StatesRZLT Rezolute Inc	323.3M	-4.4x	---
United StatesALDX Aldeyra Therapeutics Inc	328.0M	-8.6x	---
United StatesBMEA Biomea Fusion Inc	296.4M	-2.0x	---
United StatesAVIR Atea Pharmaceuticals Inc	295.5M	-1.6x	---
United StatesDSGN Design Therapeutics Inc	330.1M	-7.2x	---
As of 2024-11-11

Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Company’s products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Company’s Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.

Contact Information

Headquarters: 2701 Eastlake Ave EastSEATTLE, WA, United States 98102
Phone: 206-333-2001
Fax: 302-655-5049

Executives

Non-Executive Independent Chairman of the Board: Matthew Posard
President, Chief Executive Officer, Secretary, Director: Sujal Patel
Chief Financial Officer, Treasurer: Anna Mowry
Chief People Officer: Gwen Weld
Senior Vice President - Operations: Mary Godwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$312.7M
Revenue (TTM)	$0.00
Shares Outstanding	125.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.01
EPS	$-0.56
Book Value	$2.12
P/E Ratio	-4.3x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Nautilus Biotechnology Inc
NASDAQ:NAUTUnited States

Search Criteria

Charts

Recent News

Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones

Oct 29, 2024

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

Press Release: Nautilus Biotechnology Reports Third Quarter 2024 Financial Results, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar